GPW
BSX icon

Genesis Private Wealth’s Boston Scientific BSX Stock Holding History

Genesis Private Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,730
Closed -$267K – 183
2025
Q3 		$267K Sell
2,730
-8
-0.3% -$828 0.11% 112
2025
Q2 		$294K Buy
2,738
+26
+1% +$2.63K 0.14% 91
2025
Q1 		$274K Sell
2,712
-3
-0.1% -$302 0.15% 97
2024
Q4 		$243K Buy
+2,715
New +$239K 0.13% 103

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Genesis Private Wealth's BSX Position: Q4 2025 in Review

Genesis Private Wealth sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,730 shares — an estimated $267K sold.

Genesis Private Wealth first reported a position in BSX in Q4 2024 and held it in 4 quarters. The position peaked at $294K in Q2 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Genesis Private Wealth reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Genesis Private Wealth sold 2,730 Boston Scientific shares in Q4 2025, an estimated $267K.
  • Genesis Private Wealth first reported a position in Boston Scientific in Q4 2024 and held it in 4 quarters.
  • Genesis Private Wealth's Boston Scientific position peaked at $294K in Q2 2025.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Genesis Private Wealth's 13F filing for Q4 2025, filed 8 Jan 2026.